Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmacoitaliani is an Italian pharmaceutical company headquartered in Rome that specializes in the development, marketing, and distribution of a diverse range of healthcare products. The company's portfolio includes prescription pharmaceuticals, over-the-counter (OTC) medicines, medical devices, and nutritional supplements, with a strategic focus on therapeutic areas such as respiratory health, cardiovascular care, and musculoskeletal disorders. Farmacoitaliani operates both as a brand owner and as a commercial partner for international firms, providing comprehensive services including regulatory affairs management and distribution within the Italian market. In 2021, the company was acquired by Pharma Green Holding, a move that has strengthened its position in the Italian pharmaceutical landscape and expanded its reach through pharmacy channels. The company is dedicated to providing high-quality, accessible therapeutic solutions to meet the needs of patients and healthcare professionals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farmacoitaliani.